Современные подходы к ведению беременных пациенток с задержкой роста плода

Проведен аналитический обзор литературы по современным подходам к ведению беременных пациенток с задержкой роста плода (ЗРП), который выявил основные проблемы, касающиеся терминологии, диагностики, лечения, профилактики и родоразрешения у пациенток с данной патологией. Данные литературных источников проиллюстрированы собственными наблюдениями, которые показывают, что ЗРП остается сложной проблемой акушерства, в том числе в этическом отношении, и требует высокой степени профессиональной компетентности и ответственности при выборе тактики ведения беременности у пациенток с данным осложнением. На основании проведенного исследования сделан вывод о необходимости внедрения международных подходов к проблеме ЗРП в клиническую практику акушеров-гинекологов Республики Беларусь.

1. Blue NR, Page JM, Silver RM. Recurrence Risk of Fetal Growth Restriction: Management of Subsequent Pregnancies. Obstet Gynecol Clin North Am. 2021 Jun;48(2):419-436. DOI: https://doi.org/10.1016/j.ogc.2021.03.002

2. Клинические рекомендации, утвержденные МЗ РФ. Акушерство. Недостаточный рост плода, требующий предоставления медицинской помощи матери (задержка роста плода), ٢٠٢١. [дата обращения 2024 май 27]. Режим доступа: https://roag-portal.ru/recommendations_obstetrics

3. Доброхотова Ю.Э., Кузнецов П.А., Джохадзе Л.С., Шамугия В.В., Кравцова О.М. Недостаточный рост плода: задержка роста или малый для данного гестационного срока? Что известно о диагностике, профилактике и лечении. Гинекология. 2022;24(1):24-29. DOI: https://doi.org/10.26442/20795696.2022.1.201360

4. Westby A, Miller L. Fetal Growth Restriction Before and After Birth. Am Fam Physician. 2021;104(5):486-492.

5. Mustafa HJ, Javinani A, Muralidharan V, Khalil A. Diagnostic performance of 32 vs 36 weeks ultrasound in predicting late-onset fetal growth restriction and small-for-gestational-age neonates: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2024 Jan;6(1):101246. DOI: https://doi.org/10.1016/j.ajogmf.2023.101246

6. Powel JE, Chavan NR, Zantow EW, Bialko MF, Farley LG, McCormick KM, et al. Risk of adverse perinatal outcomes in pregnancies with “small” fetuses not meeting Delphi consensus criteria for fetal growth restriction. Am J Obstet Gynecol. 2023 Oct;229(4):447.e1-447.e13. DOI: https://doi.org/10.1016/j.ajog.2023.04.037

7. Giouleka S, Tsakiridis I, Mamopoulos A, Kalogiannidis I, Athanasiadis A, Dagklis T. Fetal Growth Restriction: A Comprehensive Review of Major Guidelines. Obstet Gynecol Surv. 2023 Nov;78(11):690-708. DOI: https://doi.org/10.1097/OGX.0000000000001203

8. Alameddine S, Capannolo G, Rizzo G, Khalil A, Di Girolamo R, Iacovella C, et al. A systematic review and critical evaluation of quality of clinical practice guidelines on fetal growth restriction. J Perinat Med. 2023 Mar 29;51(8):970-980. DOI: https://doi.org/10.1515/jpm-2022-0590

9. Melamed N, Baschat A, Yinon Y, Athanasiadis A, Mecacci F, Figueras F, et al. FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction. Int J Gynaecol Obstet. 2021 Mar;152 Suppl 1(Suppl 1):3-57. DOI: https://doi.org/10.1002/ijgo.13522

10. Beune IM, Damhuis SE, Ganzevoort W, Hutchinson JC, Khong TY, Mooney EE, et al. Consensus Definition of Fetal Growth Restriction in Intrauterine Fetal Death: A Delphi Procedure. Arch Pathol Lab Med. 2021 Apr 1;145(4):428-436. DOI: https://doi.org/10.5858/arpa.2020-0027-OA

11. Kingdom J, Ashwal E, Lausman A, Liauw J, Soliman N, Figueiro-Filho, et al. Guideline No. 442: Fetal Growth Restriction: Screening, Diagnosis, and Management in Singleton Pregnancies. J Obstet Gynaecol Can. 2023 Oct;45(10):102154. DOI: https://doi.org/10.1016/j.jogc.2023.05.022

12. Осипов Р.С., Кузнецов П.А., Джохадзе Л.С., Шугинин И.О. Что нового в предотвращении и терапии задержки роста плода? Роль оксида азота. РМЖ. Мать и дитя. 2023;6(3):258-264. DOI: https://doi.org/10.32364/2618-8430-2023-6-3-7

13. Mascherpa M, Pegoire C, Meroni A, Minopoli M, Thilaganathan B, Frick A, et al. Prenatal prediction of adverse outcome using different charts and definitions of fetal growth restriction. Ultrasound Obstet Gynecol. 2024 May;63(5):605-612. DOI: https://doi.org/10.1002/uog.27568

14. Powel JE, Chavan NR, Tomlinson TM. Fetal growth restriction or small for gestational age? Consideration of biometry alone and criteria performance. Am J Obstet Gynecol. 2023 Nov;229(5):571-572. DOI: https://doi.org/10.1016/j.ajog.2023.06.005

15. Powel JE, Chavan NR, Zantow EW, Bialko MF, Farley LG, McCormick KM, et al. Risk of adverse perinatal outcomes in pregnancies with “small” fetuses not meeting Delphi consensus criteria for fetal growth restriction. Am J Obstet Gynecol. 2023 Oct;229(4):447.e1-447.e13. DOI: https://doi.org/10.1016/j.ajog.2023.04.037

16. Schlembach D. Fetal Growth Restriction - Diagnostic Work-up, Management and Delivery. Geburtshilfe Frauenheilkd. 2020 Oct;80(10):1016-1025. DOI: https://doi.org/10.1055/a-1232-1418

17. Hoyer D, Schmidt A, Pytlik A, Viehöfer L, Gonçalves H, Amorim-Costa C, et al. Can fetal heart rate variability obtained from cardiotocography provide the same diagnostic value like from electrophysiological interbeat intervals? Physiol Meas. 2021 Feb 11;42(1):015006. DOI: https://doi.org/10.1088/1361-6579/abc791

18. Starodubtseva NL, Tokareva AO, Volochaeva MV, Kononikhin AS, Brzhozovskiy AG, Bugrova AE, et al. Quantitative Proteomics of Maternal Blood Plasma in Isolated Intrauterine Growth Restriction. Int J Mol Sci. 2023 Nov 27;24(23):16832. DOI: https://doi.org/10.3390/ijms242316832

19. Bahado-Singh, R., Turkoglu, O., Yilmaz, A., Kumar, P., Zeb, A., Konda, S., et al. Metabolomic identification of placental alterations in fetal growth restriction. The Journal of Maternal-Fetal & Neonatal Medicine. 2020;35:447-456. DOI: https://doi.org/10.1080/14767058.2020.1722632

20. Yang J, Liu Y, Dong M. Integrated Bioinformatics Analysis to Screen Hub Gene Signatures for Fetal Growth Restriction. Genet Res (Camb). 2023 Mar 30;2023:3367406. DOI: https://doi.org/10.1155/2023/3367406

21. Волочаева М.В., Токарева А.О., Кононихин А.С., Кукаев Е.Н., Тютюнник В.Л., Кан Н.Е. и др. Диагностическая значимость протеомного анализа плазмы крови при задержке роста плода. Акушерство и гинекология. 2024;(4):59-68. DOI: https://doi.org/10.18565/aig.2023.299

22. Eroğlu H, Tonyalı NV, Orgul G, Biriken D, Yucel A, Yazihan N, Uygur D. Is ProBNP a New Marker for Predicting Intrauterine Growth Restriction? Z Geburtshilfe Neonatol. 2021 Apr;225(2):125-128. DOI: https://doi.org/10.1055/a-1382-8787

23. Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2022 Feb;226(2S):S1108-S1119. DOI: https://doi.org/10.1016/j.ajog.2020.08.045

24. D’Antonio F, Khalil A, Rizzo G, Fichera A, Herrera M, Buca D, et al. Aspirin for prevention of preeclampsia and adverse perinatal outcome in twin pregnancies: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023 Feb;5(2):100803. DOI: https://doi.org/10.1016/j.ajogmf.2022.100803

25. Hamulyák EN, Scheres LJ, Marijnen MC, Goddijn M, Middeldorp S. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. Cochrane Database Syst Rev. 2020 May 2;5(5):CD012852. DOI: https://doi.org/10.1002/14651858.CD012852.pub2

26. Massimiani M, Tiralongo GM, Salvi S, Fruci S, Lacconi V, La Civita F, et al. Treatment of pregnancies complicated by intrauterine growth restriction with nitric oxide donors increases placental expression of Epidermal Growth Factor-Like Domain 7 and improves fetal growth: A pilot study. Transl Res. 2021 Feb;228:28-41. DOI: https://doi.org/10.1016/j.trsl.2020.08.002

27. Rakhanova Y, Almawi WY, Aimagambetova G, Riethmacher D. The effects of sildenafil citrate on intrauterine growth restriction: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2023 Jun 2;23(1):409. DOI: https://doi.org/10.1186/s12884-023-05747-7

28. Kitase Y, Sato Y, Arai S, Onoda A, Ueda K, Go S, et al. Establishment of a Novel Fetal Growth Restriction Model and Development of a Stem-Cell Therapy Using Umbilical Cord-Derived Mesenchymal Stromal Cells. Front Cell Neurosci. 2020 Jul 28;14:212. DOI: https://doi.org/10.3389/fncel.2020.00212

29. Wilson RL, Lampe K, Gupta MK, Duvall CL, Jones HN. Nanoparticle-mediated transgene expression of insulin-like growth factor 1 in the growth restricted guinea pig placenta increases placenta nutrient transporter expression and fetal glucose concentrations. Mol Reprod Dev. 2022 Nov;89(11):540-553. DOI: https://doi.org/10.1002/mrd.23644

30. Kinoshita M, Crispi F, Loreiro C, Gratacós E, Illa M, Zamora M. Strategies for intra-amniotic administration of fetal therapy in a rabbit model of intrauterine growth restriction. Experimental Biology and Medicine. 2021;246:1668-1679. DOI: https://doi.org/10.1177/15353702211003508

31. Sacchi C, Marino C, Nosarti C, Vieno A, Visentin S, Simonelli A. Association of Intrauterine Growth Restriction and Small for Gestational Age Status with Childhood Cognitive Outcomes: A Systematic Review and Meta-analysis. JAMA Pediatr. 2020 Aug 1;174(8):772-781. DOI: https://doi.org/10.1001/jamapediatrics.2020.1097